Showing results (1881-1890 of 2,188) with videos related to

Sort By:
Pageof 219
Alcoholism, Clinical and Experimental Research|April 1, 1995
A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disordersB J Powell, J L Campbell, J F Landon, et al.
Journal of Medicinal Chemistry|September 10, 2009
Rapid generation of a high quality lead for transforming growth factor-beta (TGF-beta) type I receptor (ALK5)Frederick W Goldberg, Richard A Ward, Steven J Powell, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 21, 2022
Impact of maternal social vulnerability and timing of prenatal care on outcome of prenatally detected congenital heart diseaseM T Perez, E Bucholz, E Asimacopoulos, et al.
Cell Reports Methods|March 20, 2023
Label-free cell segmentation of diverse lymphoid tissues in 2D and 3DJohn W Wills, Jack Robertson, Pani Tourlomousis, et al.
Frontiers in Cardiovascular Medicine|August 21, 2023
Right ventricular contraction patterns in healthy children using three-dimensional echocardiographyChristopher Valle, Adrienn Ujvari, Eleni Elia, et al.
Implementation Research and Practice|April 24, 2023
A scoping review of strategies for financing the implementation of evidence-based practices in behavioral health systems: State of the literature and future directionsAlex R Dopp, Marie-Rachelle Narcisse, Peter Mundey, et al.
Cancer Research|January 19, 1999
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor typesT A Fong, L K Shawver, L Sun, et al.
Implementation Science : IS|May 13, 2017
The association between implementation strategy use and the uptake of hepatitis C treatment in a national sampleShari S Rogal, Vera Yakovchenko, Thomas J Waltz, et al.
Journal of the American Chemical Society|March 20, 2020
Quantitative Control of Gene-Engineered T-Cell Activity through the Covalent Attachment of Targeting Ligands to a Universal Immune ReceptorNicholas G Minutolo, Prannda Sharma, Mathilde Poussin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 2, 2014
Nanoparticulate iron(III) oxo-hydroxide delivers safe iron that is well absorbed and utilised in humansDora I A Pereira, Sylvaine F A Bruggraber, Nuno Faria, et al.
Pageof 219